Aggregated China Business Blogs



China’s Gene Therapy Cancer Drugs: Slow Acceptance of Great Science

Aggregated Source: China Stocks News and Analysis from Seeking Alpha
January 1, 2008|

In a recent article, Bloomberg profiled Shanghai Sunway Biotech Co., detailing the career path of its founder, Dr. Hu Fang. The article uses the highly picturesque image of Hu’s career beginnings as a “barefoot doctor,” ordered at age 19 to the provinces to tend the rural population during the Great Leap Forward of the 1960s, sent without the benefit of medicines or instruments.

Original URL: Click here to visit original article
Copyright China Stocks News and Analysis from Seeking Alpha

Print This Post Print This Post | Email This Page Email This Page
No Ratings Yet
Loading ... Loading ...

Related Info:
  • 3 Reasons Why Benda Pharmaceutical's Share Price Is Depressed
  • Sunway and Genzyme to Collaborate on Gene Therapy
  • Benda's Jiangling Plant Receives Production Approval
  • China Biotech Week in Review: Benda Pharma Qualifies for Nasdaq Listing
  • Gene Therapy and Anti-Aging Treatments on Top of China Biopharma Agenda

    • No Comments Yet »

    Your comment

    The following HTML tags are permitted:
    <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>

    RSS RSS Feed for Comments on this Post |